Home
Sudarshan Pharma Industries Ltd Share Price History
Sudarshan Pharma Industries Ltd
BSE : 17 Jan, 2025
44.14-0.9 (-2.0%)
Prev Close
45.0
Open Price
44.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
96000
Today's High / Low
44.1 / 44.1
52 WK High / Low
53.5 / 5.8
Market Price of Sudarshan Pharma Industries Ltd
1M
1Y
3Y
5Y
Monitoring Sudarshan Pharma Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2020 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 1.34 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 20.78 |
Key Financial Parameters
| Parameter | 2020 |
|---|---|
| Return on Capital Emp. % | 10.92 |
| Op. Profit Mgn % | 3.23 |
| Net Profit Mgn % | 0.86 |
| Debt to Equity % | 1.05 |
Latest Shareholding
Promoters Holdings Over Time
About Sudarshan Pharma Industries Ltd
- Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name 'Sudarshan Specialty Chemsolve Private Limited' on July 23, 2008 with the Registrar of Companies, Mumbai.
- Later in the year 2016. name of the Company was changed from 'Sudarshan Specialty Chemsolve Private Limited' to 'Sudarshan Pharma Industries Private Limited' on 17 December 2016.
- Thereafter, the Company converted into a Public Limited pursuant to a special resolution passed by shareholders at the EGM held on December 12, 2016 and consequently, name of the Company was changed to 'Sudarshan Pharma Industries Limited' on January 5, 2017. The Company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry.
FAQs for Sudarshan Pharma Industries Ltd Share Price History
What are the key events that typically impact Sudarshan Pharma Industries Ltd's share price history?
Key events that impact Sudarshan Pharma Industries Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Sudarshan Pharma Industries Ltd's share price history?
Stock splits reduce the nominal price of Sudarshan Pharma Industries Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Sudarshan Pharma Industries Ltd?
Dividends can influence Sudarshan Pharma Industries Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Sudarshan Pharma Industries Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Sudarshan Pharma Industries Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Sudarshan Pharma Industries Ltd’s share price history?
To understand Sudarshan Pharma Industries Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
